Stock Scorecard
Stock Summary for Quest Diagnostics Inc (DGX) - $161.16 as of 11/20/2024 3:57:56 PM EST
Total Score
10 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DGX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DGX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DGX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DGX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DGX (68 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 7 |
Latest News for for DGX
Financial Details for DGX
Company Overview |
|
|---|---|
| Ticker | DGX |
| Company Name | Quest Diagnostics Inc |
| Country | USA |
| Description | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 1/30/2025 |
Stock Price History |
|
| Last Day Price | 161.16 |
| Price 4 Years Ago | 110.07 |
| Last Day Price Updated | 11/20/2024 3:57:56 PM EST |
| Last Day Volume | 763,610 |
| Average Daily Volume | 895,125 |
| 52-Week High | 162.88 |
| 52-Week Low | 121.08 |
| Last Price to 52 Week Low | 33.10% |
Valuation Measures |
|
| Trailing PE | 21.63 |
| Industry PE | 51.15 |
| Sector PE | 40.32 |
| 5-Year Average PE | 15.00 |
| Free Cash Flow Ratio | 23.56 |
| Industry Free Cash Flow Ratio | 10.25 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 1.25 |
| Total Cash Per Share | 6.84 |
| Book Value Per Share Most Recent Quarter | 60.80 |
| Price to Book Ratio | 2.64 |
| Industry Price to Book Ratio | 1.89 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 1.89 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.70 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 111,615,000 |
| Market Capitalization | 17,987,873,400 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 1/14/2025 |
| Last Dividend Amount | 0.75 |
| Current Dividend Amount | 0.75 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.71 |
| Trailing Annual Dividend Yield | 2.30% |
| Forward Annual Dividend Rate | 3.97 |
| Forward Annual Dividend Yield | 2.47% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 1.69% |
| 5-Year Average Dividend Yield | 1.78% |
| 1-Year Dividend Growth Rate Percentage | 7.31% |
| 3-Year Dividend Growth Rate Percentage | 7.37% |
| 5-Year Dividend Growth Rate Percentage | 7.11% |
| All-Time Dividend Growth Rate Percentage | 11.14% |
| Dividend Payout Ratio | 49.80% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 1.50% |
| Annual Earnings Growth | -9.73% |
| Reported EPS 12 Trailing Months | 7.45 |
| Reported EPS Past Year | 6.69 |
| Reported EPS Prior Year | 8.71 |
| Net Income Twelve Trailing Months | 841,000,000 |
| Net Income Past Year | 854,000,000 |
| Net Income Prior Year | 946,000,000 |
| Quarterly Revenue Growth YOY | 8.40% |
| 5-Year Revenue Growth | 3.86% |
| Operating Margin Twelve Trailing Months | 0.14 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 764,000,000 |
| Total Cash Past Year | 686,000,000 |
| Total Cash Prior Year | 315,000,000 |
| Net Cash Position Most Recent Quarter | -5,487,000,000 |
| Net Cash Position Past Year | -4,027,000,000 |
| Long Term Debt Past Year | 4,713,000,000 |
| Long Term Debt Prior Year | 3,980,000,000 |
| Total Debt Most Recent Quarter | 6,251,000,000 |
| Equity to Debt Ratio Past Year | 0.57 |
| Equity to Debt Ratio Most Recent Quarter | 0.52 |
| Total Stockholder Equity Past Year | 6,307,000,000 |
| Total Stockholder Equity Prior Year | 5,893,000,000 |
| Total Stockholder Equity Most Recent Quarter | 6,809,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,023,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.17 |
| Free Cash Flow Past Year | 864,000,000 |
| Free Cash Flow Prior Year | 1,314,000,000 |
Options |
|
| Put/Call Ratio | 0.53 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.91 |
| MACD Signal | 1.60 |
| 20-Day Bollinger Lower Band | 142.42 |
| 20-Day Bollinger Middle Band | 152.23 |
| 20-Day Bollinger Upper Band | 162.03 |
| Beta | 0.89 |
| RSI | 61.41 |
| 50-Day SMA | 139.55 |
| 150-Day SMA | 134.26 |
| 200-Day SMA | 133.33 |
System |
|
| Modified | 11/20/2024 11:04:34 PM EST |